Financial and ethical safety in cancer care
9 Sep 2017
Financial and ethical safety in cancer care
Phase Ib/II trial of combination PD-1 therapy against kidney cancer
PACIFIC trial of durvalumab for stage III NSCLC
Emerging targets for the treatment of lung cancer
Managing osteonecrosis of the jaw
New treatment avenues in squamous cell carcinoma
Identifying rare mutations in lung cancer
Lung cancer advances beyond PD1
Current and future prospects in treating multiple myeloma
Haematology advances in review
WIN 2017 conference review
The challenge of approving add-on therapies for patients with metastatic cancer